1. Home
  2. UNCY vs LASE Comparison

UNCY vs LASE Comparison

Compare UNCY & LASE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNCY
  • LASE
  • Stock Information
  • Founded
  • UNCY 2016
  • LASE 2019
  • Country
  • UNCY United States
  • LASE United States
  • Employees
  • UNCY N/A
  • LASE N/A
  • Industry
  • UNCY Biotechnology: Pharmaceutical Preparations
  • LASE Industrial Machinery/Components
  • Sector
  • UNCY Health Care
  • LASE Industrials
  • Exchange
  • UNCY Nasdaq
  • LASE Nasdaq
  • Market Cap
  • UNCY 71.8M
  • LASE 36.3M
  • IPO Year
  • UNCY 2021
  • LASE 2022
  • Fundamental
  • Price
  • UNCY $0.65
  • LASE $2.87
  • Analyst Decision
  • UNCY Strong Buy
  • LASE
  • Analyst Count
  • UNCY 3
  • LASE 0
  • Target Price
  • UNCY $5.50
  • LASE N/A
  • AVG Volume (30 Days)
  • UNCY 1.0M
  • LASE 124.7K
  • Earning Date
  • UNCY 05-12-2025
  • LASE 05-13-2025
  • Dividend Yield
  • UNCY N/A
  • LASE N/A
  • EPS Growth
  • UNCY N/A
  • LASE N/A
  • EPS
  • UNCY N/A
  • LASE N/A
  • Revenue
  • UNCY N/A
  • LASE $3,077,760.00
  • Revenue This Year
  • UNCY N/A
  • LASE N/A
  • Revenue Next Year
  • UNCY $1,502.84
  • LASE N/A
  • P/E Ratio
  • UNCY N/A
  • LASE N/A
  • Revenue Growth
  • UNCY N/A
  • LASE 0.93
  • 52 Week Low
  • UNCY $0.20
  • LASE $1.58
  • 52 Week High
  • UNCY $1.29
  • LASE $19.80
  • Technical
  • Relative Strength Index (RSI)
  • UNCY 59.77
  • LASE 47.52
  • Support Level
  • UNCY $0.63
  • LASE $2.77
  • Resistance Level
  • UNCY $0.66
  • LASE $3.08
  • Average True Range (ATR)
  • UNCY 0.03
  • LASE 0.24
  • MACD
  • UNCY 0.01
  • LASE 0.07
  • Stochastic Oscillator
  • UNCY 84.35
  • LASE 61.54

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

About LASE Laser Photonics Corporation

Laser Photonics Corp is an integrated manufacturing company for photonics-based industrial products and solutions, primarily laser cleaning technologies. Its laser-blasting technologies are focused on disrupting the sandblasting and abrasives blasting markets. The company offers a portfolio of integrated laser-blasting solutions for corrosion control, rust removal, de-coating, pre-welding and post-welding, laser cleaning, and surface conditioning. Its laser-blasting solutions are applicable in every industry dealing with materials processing, including automotive, aerospace, healthcare, consumer products, shipbuilding, aerospace, machine manufacturing, nuclear maintenance and de-commissioning, and surface coating.

Share on Social Networks: